Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1275 of 1863 entries
View as:

Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel

Phase: N/A Priority: Normal
NCT ID: NCT00705835 Org: User:
Start: 01/31/03 End: 01/31/08 Due: 01/31/09

Cardiac Monitoring of Post-Operative Cancer Patients Experiencing Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT01253590 Org: User:
Start: 12/31/10 End: 11/30/11 Due: 11/30/12

A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02831686 Org: User:
Start: 07/31/16 End: 11/19/20 Due: 11/19/21

Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00045422 Org: User:
Start: 04/30/02 End: 10/31/03 Due: 10/31/04

Imaging With a New Agent That Finds a Cancer Protein Called HER2

Phase: N/A Priority: Normal
NCT ID: NCT03109977 Org: User:
Start: 03/31/17 End: 04/12/18 Due: 04/12/19

Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib

Phase: N/A Priority: Normal
NCT ID: NCT02155465 Org: User:
Start: 06/30/14 End: 10/31/17 Due: 10/31/18

Body Composition and White Adipose Tissue Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT02713022 Org: User:
Start: 11/04/15 End: 11/07/23 Due: 11/07/24

GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02360111 Org: User:
Start: 02/28/15 End: 09/30/17 Due: 09/30/18

Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00579423 Org: User:
Start: 11/30/00 End: 03/31/09 Due: 03/31/10

Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT

Phase: N/A Priority: Normal
NCT ID: NCT00648037 Org: User:
Start: 03/31/08 End: 12/31/08 Due: 12/31/09

A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04848961 Org: User:
Start: 04/09/21 End: 04/09/26 Due: 04/09/27

Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners

Phase: N/A Priority: Normal
NCT ID: NCT00483678 Org: User:
Start: 04/30/07 End: 03/01/18 Due: 03/01/19

FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01864083 Org: User:
Start: 05/31/13 End: 08/29/17 Due: 08/29/18

Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00897702 Org: User:
Start: 01/09/07 End: 01/31/26 Due: 01/31/27

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03220646 Org: User:
Start: 07/13/17 End: 07/31/25 Due: 07/31/26

Menstrual Cycle Maintenance and Quality of Life: A Prospective Study

Phase: N/A Priority: Normal
NCT ID: NCT00589654 Org: User:
Start: 12/31/97 End: 12/31/25 Due: 12/31/26

A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04556266 Org: User:
Start: 07/01/21 End: 03/01/22 Due: 03/01/23

HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/ET

Phase: N/A Priority: Normal
NCT ID: NCT01668173 Org: User:
Start: 08/31/12 End: 05/31/15 Due: 05/31/16

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003427 Org: User:
Start: 04/30/98 End: 04/30/02 Due: 04/30/03

A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT06594991 Org: User:
Start: 09/10/24 End: 09/30/27 Due: 09/30/28

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

Phase: N/A Priority: Normal
NCT ID: NCT03269994 Org: User:
Start: 11/21/17 End: 01/28/25 Due: 01/28/26

Psychotherapy Intervention for Latinos With Adv Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04537936 Org: User:
Start: 01/01/19 End: 08/31/25 Due: 08/31/26

Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03524326 Org: User:
Start: 04/30/18 End: 10/13/22 Due: 10/13/23

Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02966730 Org: User:
Start: 11/30/16 End: 06/20/19 Due: 06/20/20

Psychotherapy Intervention for Latinos With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04015609 Org: User:
Start: 04/20/15 End: 08/31/25 Due: 08/31/26